# VIRACTA THERAPEUTICS INC (VIRX)

> Institutional ownership reported to the SEC as of Q1 2025, from Form 13F filings. Source: https://holderbook.com/stocks/VIRX/

- Reporting holders: 5
- Reported value: $3.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $2.2K | 93,391 | 0.0% | 7 |
| [UNITED CAPITAL FINANCIAL ADVISORS, LLC](https://holderbook.com/funds/1463217-united-capital-financial-advisors-llc/) | $860 | 42,995 | 0.0% | 3 |
| [WealthTrust Axiom LLC](https://holderbook.com/funds/1425949-wealthtrust-axiom-llc/) | $384 | 16,396 | 0.0% | 5 |
| [Baader Bank Aktiengesellschaft](https://holderbook.com/funds/1542629-baader-bank-aktiengesellschaft/) | $283 | 15,265 | 0.0% | 2 |
| [RP Management, LLC](https://holderbook.com/funds/1507673-rp-management-llc/) | $74 | 3,700 | 0.0% | 17 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2025 | 5 | $3.8K |
| Q4 2024 | 32 | $583.3K |
| Q3 2024 | 37 | $1.3M |
| Q2 2024 | 39 | $4.9M |
| Q1 2024 | 40 | $9.8M |
| Q4 2023 | 42 | $5.6M |
| Q3 2023 | 41 | $10.1M |
| Q2 2023 | 41 | $14.1M |
| Q1 2023 | 48 | $19.5M |
| Q4 2022 | 55 | $18.1M |
| Q3 2022 | 55 | $53.6M |
| Q2 2022 | 58 | $45.2M |